Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 36

    1.

    Quantifying the potential benefit of sigmoidoscopic rescreening for colorectal cancer.

    Weiss NS, Newcomb PA.

    J Natl Cancer Inst. 2012 Feb 22;104(4):259-60. Epub 2012 Jan 31. No abstract available.

    PMID:
    22298837
    [PubMed - indexed for MEDLINE]
    2.

    New data on aspirin and colorectal cancer brings calls for new guidelines, more research.

    McNeil C.

    J Natl Cancer Inst. 2012 Feb 8;104(3):172-7. Epub 2012 Jan 23. No abstract available.

    PMID:
    22271767
    [PubMed - indexed for MEDLINE]
    3.

    Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.

    Sanoff HK, Carpenter WR, Martin CF, Sargent DJ, Meyerhardt JA, Stürmer T, Fine JP, Weeks J, Niland J, Kahn KL, Schymura MJ, Schrag D.

    J Natl Cancer Inst. 2012 Feb 8;104(3):211-27. Epub 2012 Jan 20.

    PMID:
    22266473
    [PubMed - indexed for MEDLINE]
    4.

    Less is more: not "going the distance" and why.

    Harris R, Kinsinger LS.

    J Natl Cancer Inst. 2011 Dec 7;103(23):1726-8. Epub 2011 Nov 9. No abstract available.

    PMID:
    22076286
    [PubMed - indexed for MEDLINE]
    5.

    Fecal occult blood testing when colonoscopy capacity is limited.

    Wilschut JA, Habbema JD, van Leerdam ME, Hol L, Lansdorp-Vogelaar I, Kuipers EJ, van Ballegooijen M.

    J Natl Cancer Inst. 2011 Dec 7;103(23):1741-51. Epub 2011 Nov 9.

    PMID:
    22076285
    [PubMed - indexed for MEDLINE]
    6.

    Delta-like ligand 4-notch blockade and tumor radiation response.

    Liu SK, Bham SA, Fokas E, Beech J, Im J, Cho S, Harris AL, Muschel RJ.

    J Natl Cancer Inst. 2011 Dec 7;103(23):1778-98. Epub 2011 Oct 18.

    PMID:
    22010178
    [PubMed - indexed for MEDLINE]
    7.

    The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma.

    Ai J, Tang Q, Wu Y, Xu Y, Feng T, Zhou R, Chen Y, Gao X, Zhu Q, Yue X, Pan Q, Xu S, Li J, Huang M, Daugherty-Holtrop J, He Y, Xu HE, Fan J, Ding J, Geng M.

    J Natl Cancer Inst. 2011 Nov 16;103(22):1696-712. Epub 2011 Oct 24.

    PMID:
    22025622
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Rewriting the mathematics of tumor growth.

    Martin M.

    J Natl Cancer Inst. 2011 Nov 2;103(21):1564-5. Epub 2011 Oct 18. No abstract available.

    PMID:
    22010175
    [PubMed - indexed for MEDLINE]
    9.

    Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.

    Yothers G, Sargent DJ, Wolmark N, Goldberg RM, O'Connell MJ, Benedetti JK, Saltz LB, Dignam JJ, Blackstock AW; ACCENT Collaborative Group.

    J Natl Cancer Inst. 2011 Oct 19;103(20):1498-506. Epub 2011 Oct 12.

    PMID:
    21997132
    [PubMed - indexed for MEDLINE]
    10.

    Race and subset analyses in clinical trials: time to get serious about data integration.

    Polite BN, Sylvester BE, Olopade OI.

    J Natl Cancer Inst. 2011 Oct 19;103(20):1486-8. Epub 2011 Oct 12. No abstract available.

    PMID:
    21997133
    [PubMed - indexed for MEDLINE]
    11.

    Re: a case-control study of levothyroxine and the risk of colorectal cancer.

    Friedman GD, Schwalbe JS, Habel LA.

    J Natl Cancer Inst. 2011 Nov 2;103(21):1637-9. Epub 2011 Oct 18. No abstract available.

    PMID:
    22010174
    [PubMed - indexed for MEDLINE]
    12.

    StatBite. U.S. cancer care expenditures in 2010.

    [No authors listed]

    J Natl Cancer Inst. 2011 Oct 5;103(19):1435. Epub 2011 Sep 20. No abstract available.

    PMID:
    21934076
    [PubMed - indexed for MEDLINE]
    13.

    Model-based analyses to compare health and economic outcomes of cancer control: inclusion of disparities.

    Goldie SJ, Daniels N.

    J Natl Cancer Inst. 2011 Sep 21;103(18):1373-86. Epub 2011 Sep 6.

    PMID:
    21900120
    [PubMed - indexed for MEDLINE]
    14.

    Screening for colorectal cancer--which strategy is the best?

    Church TR.

    J Natl Cancer Inst. 2011 Sep 7;103(17):1282-3. Epub 2011 Aug 18. No abstract available.

    PMID:
    21852265
    [PubMed - indexed for MEDLINE]
    15.

    Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.

    Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, Andreoni B, Arrigoni A, Bisanti L, Casella C, Crosta C, Falcini F, Ferrero F, Giacomin A, Giuliani O, Santarelli A, Visioli CB, Zanetti R, Atkin WS, Senore C; SCORE Working Group.

    J Natl Cancer Inst. 2011 Sep 7;103(17):1310-22. Epub 2011 Aug 18. Erratum in: J Natl Cancer Inst. 2011 Dec 21;103(24):1903. Fracchia, M [added].

    PMID:
    21852264
    [PubMed - indexed for MEDLINE]
    16.

    Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.

    Ng K, Ogino S, Meyerhardt JA, Chan JA, Chan AT, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Benson AB 3rd, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Bertagnolli MM, Venook AP, Fuchs CS.

    J Natl Cancer Inst. 2011 Oct 19;103(20):1540-51. Epub 2011 Aug 17.

    PMID:
    21849660
    [PubMed - indexed for MEDLINE]
    17.

    Re: Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations.

    Brandi G, Biasco G, Tavolari S.

    J Natl Cancer Inst. 2011 Aug 17;103(16):1278. Epub 2011 Jul 20. No abstract available.

    PMID:
    21775746
    [PubMed - indexed for MEDLINE]
    18.

    Effect of misclassified underlying cause of death on survival estimates of colon and rectal cancer.

    Yin D, Morris CR, Bates JH, German RR.

    J Natl Cancer Inst. 2011 Jul 20;103(14):1130-3. Epub 2011 Jun 22.

    PMID:
    21697545
    [PubMed - indexed for MEDLINE]
    19.

    Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.

    Helfman DM.

    J Natl Cancer Inst. 2011 Jul 6;103(13):991-2. Epub 2011 Jun 17. No abstract available.

    PMID:
    21685360
    [PubMed - indexed for MEDLINE]
    20.

    Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes.

    Potosky AL, Malin JL, Kim B, Chrischilles EA, Makgoeng SB, Howlader N, Weeks JC.

    J Natl Cancer Inst. 2011 Jun 22;103(12):979-82. doi: 10.1093/jnci/djr152. Epub 2011 Jun 13.

    PMID:
    21670423
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk